Search

everythinglearnresearchcommunity

for

Search:↓

Certolizumab effectively treats psoriasis and psoriatic arthritis with fewer side effects than adalimumab.

Selective immunotherapies like anifrolumab and belimumab are more effective for treating systemic lupus erythematosus than traditional drugs.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Belimumab may cause hair loss in lupus patients.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Infliximab can trigger lupus-like symptoms in Crohn's disease patients.

A girl with Evans' syndrome had her low platelet count successfully treated with zanubrutinib.

A patient with multiple sclerosis developed skin reactions after Daclizumab treatment, requiring more data on the drug's effects.

Hair dye may trigger anti-GBM disease relapse, and rituximab can help manage it.

A man had a severe allergic reaction to sulfasalazine, with symptoms improving after treatment and follow-up.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

PX-12 may help treat psoriasis by blocking inflammation and cell death.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Aggressive immunosuppressive treatment improved a woman's severe heart condition linked to autoimmune disease.

Stopping the medication infliximab and starting new treatments helped a woman's hair grow back and improved her scalp condition.

Clofazimine effectively treated ashy dermatosis in a patient.

A combination of ixekizumab and tofacitinib successfully treated severe scalp cellulitis, leading to hair regrowth.

Baricitinib is more effective than methotrexate for severe alopecia areata.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

A patient with a nerve disorder died from infection complications after developing insulin resistance from a treatment.

The article concludes that proper injection techniques and patient education can prevent serious skin reactions from multiple sclerosis medications.

Adalimumab significantly improved symptoms and quality of life in two patients with Hidradenitis Suppurativa.

Early use of infliximab in severe pediatric Crohn's disease can lead to significant improvement and remission.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Rituximab leads to longer remission and fewer side effects than cyclophosphamide.

Promising cancer treatments were found, but the manufacturer closed.

Bortezomib chemotherapy can cause temporary skin rashes.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.